Advertisement

Abdominal Imaging

, Volume 32, Issue 6, pp 719–724 | Cite as

Hemobilia after radiofrequency ablation of hepatocellular carcinoma

  • Hyunchul Rhim
  • Hyo K. LimEmail author
  • Young-Sun Kim
  • Dongil Choi
  • Kyu Taek Lee
Article

Abstract

Objective

The purpose of this study was to report on the clinical course and imaging findings of hemobilia after radiofrequency (RF) ablation in four patients with hepatocellular carcinoma (HCC).

Materials and methods

From July 2000 to December 2005, we experienced four cases of hemobilia after 1574 sessions of ultrasonography (US)-guided RF ablation in 1037 patients with HCCs. All ablation procedures were percutaneously performed with an internally cooled RF electrode system. The diagnosis of hemobilia was made if the patient complained of melena after RF ablation and biliary dilatation with high attenuating bile was noted at CT obtained immediately after RF ablation. We evaluated the clinical course and imaging findings of hemobilia caused by RF ablation.

Results

All patient well tolerated RF ablation procedures without any incident during the procedure. Three of four patients complained of melena with an interval from 1 day to 4 days after RF ablation. One patient was asymptomatic. The melena symptom in all symptomatic patients spontaneously improved in 2 days. None of the patients showed substantial change in vital sign and the level of hemoglobin during the admission period. In all four patients, biliary (including GB) dilatation with high attenuating bile was noted at immediate follow-up CT. The CT findings in all four patients disappeared at 1 month follow-up CT.

Conclusion

Hemobilia is a rare potential complication of RF ablation with a favorable prognosis. Clinicians who use this technique should be aware of the characteristic CT findings and clinical course of hemobilia after RF ablation for liver tumors.

Keywords

Radiofrequency ablation Hepatocellular carcinoma Complication Hemobilia 

References

  1. 1.
    Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRefGoogle Scholar
  2. 2.
    Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235(3):728–739. Epub 2005 Apr 21. (review)Google Scholar
  3. 3.
    Dodd GD 3rd, Soulen MC, Kane RA, et al. (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20(1):9–27 (review)Google Scholar
  4. 4.
    Tateishi R, Shiina S, Teratani T (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma: an analysis in 1000 cases. Cancer 103:1201–1209PubMedCrossRefGoogle Scholar
  5. 5.
    Lencioni R, Cioni D, Crocetti L, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3):961–967PubMedCrossRefGoogle Scholar
  6. 6.
    Mulier S, Mulier P, Ni Y, et al. (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206–1222PubMedCrossRefGoogle Scholar
  7. 7.
    Livraghi T, Solbiati L, Meloni MF, et al. (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226(2):441–451PubMedCrossRefGoogle Scholar
  8. 8.
    Rhim H, Yoon KH, Lee JM, et al. (2003) Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 23(1):123–134; discussion 134–136Google Scholar
  9. 9.
    Curley SA, Marra P, Beaty K, et al. (2004) Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239(4):450–458PubMedCrossRefGoogle Scholar
  10. 10.
    Akahane M, Koga H, Kato N, et al. (2005) Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 1(25 Suppl):S57–S68CrossRefGoogle Scholar
  11. 11.
    Kim SH, Lim HK, Choi D, et al. (2004) Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol 183(6):1611–1167PubMedGoogle Scholar
  12. 12.
    Enne M, Pacheco-Moreira LF, Cerqueira A, et al. (2004) Fatal hemobilia after radiofrequency thermal ablation for hepatocellular carcinoma. Surgery 135(4):460–461PubMedCrossRefGoogle Scholar
  13. 13.
    Lim HK, Choi D, Lee WJ, et al. (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221(2):447–454PubMedCrossRefGoogle Scholar
  14. 14.
    Obi S, Shiratori Y, Shiina S, et al. (2000) Early detection of hemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 12(3):285–290PubMedCrossRefGoogle Scholar
  15. 15.
    Joo YE, Kim HS, Choi SK, et al. (2003) Hemobilia caused by liver abscess due to intrahepatic duct stones. J Gastroenterol 38(5):507–511PubMedCrossRefGoogle Scholar
  16. 16.
    Yamamoto T, Kubo S, Hirohashi K (2003) Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. J Gastroenterol 38(4):399–403 (review)Google Scholar
  17. 17.
    Rhim H (2005) Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 30(4):409–418 (review)Google Scholar
  18. 18.
    Xu ZB, Zhou XY, Peng ZY, et al. (2005) Evaluation of selective hepatic angiography and embolization in patients with massive hemobilia. Hepatobiliary Pancreat Dis Int 4(2):254–258PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Hyunchul Rhim
    • 1
  • Hyo K. Lim
    • 1
    Email author
  • Young-Sun Kim
    • 1
  • Dongil Choi
    • 1
  • Kyu Taek Lee
    • 2
  1. 1.Department of Radiology and Center for Imaging Science, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulSouth Korea
  2. 2.Department of Internal Medicine, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulSouth Korea

Personalised recommendations